Everything we know about the Covid vaccine to be made on Teesside A VACCINE from Novavax, which will be manufactured in the North-East, has been shown to be 89 per cent effective in preventing Covid-19 - but what else do we know about it? The Novavax coronavirus vaccine has passed its third and final stage of clinical trials, offering an additional glimmer of hope as the UK continues to vaccinate vulnerable groups. The manufacturing of this Covid-19 vaccine, of which the UK has secured 60 million doses, is set to take place at Fujifilm Diosynth in Billingham, on Teesside. Teessiders have been quick to welcome the news, which has been supported by Prime Minister Boris Johnson and Health Secretary Matt Hancock.
New UK-made Covid vaccine could be approved in weeks - this is how the Novavax jab works
The Covid-19 vaccine from Novavax, which was extensively tested in the UK, has been shown to prevent infection
direct to your inboxInvalid EmailSomething went wrong, please try again later.
Click here
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
When will the Novavax vaccine be available in the UK?
As the Novavax vaccine has not yet been approved by the MHRA in the UK, it is not yet available.
However, it looks likely it will be approved in the coming month, meaning rollout of Novavax could begin in the late spring.
While other vaccines currently available are believed to be effective against the several new strains of the virus that have emerged worldwide in recent weeks and months, the news of a vaccine that can keep pace with any new variants is particularly optimistic.
Professor Paul Heath, who led the Novavax trials, said the results were yet another great step forward for the UK”.